Antivirals: Difference between revisions
ClaireLewis (talk | contribs) No edit summary |
ClaireLewis (talk | contribs) (→HAART) |
||
| Line 20: | Line 20: | ||
==HAART== | ==HAART== | ||
*HIV regimen that typically consists of combination of 2 nucleoside and/or non-nucleoside reverse transcriptase inhibitors PLUS a protease inhibitor, reverse-transcriptase inhibitor, or integrase inhibitor | |||
*US DHHS first-line regimens | |||
**[[Emtricitabine/tenofovir]] (Truvada) + raltegravir | |||
**[[Emtricitabine/tenofovir]] + dolutegravir | |||
**Abacavir/lamivudine( (Epzicom) + dolutegravir OR abacavir/lamivudine/dolutegravir (Triumeq) | |||
**[[Emtricitabine/tenofovir]]/elvitegravir/cobicistat (Stribild) | |||
**[[Emtricitabine/tenofovir]] + ritonavir + darunavir | |||
*WHO first-line regimen | |||
**[[Emtricitabine/tenofovir]]/efavirenz (Atripla) | |||
**Tenofovir + lamivudine + efavirenz | |||
==Other== | ==Other== | ||
Revision as of 01:08, 26 February 2017
Anti-herpetic agents
Anti-influenza agents
Adamantane Derivatives
Neuraminidase Inhibitors
Interferons
HAART
- HIV regimen that typically consists of combination of 2 nucleoside and/or non-nucleoside reverse transcriptase inhibitors PLUS a protease inhibitor, reverse-transcriptase inhibitor, or integrase inhibitor
- US DHHS first-line regimens
- Emtricitabine/tenofovir (Truvada) + raltegravir
- Emtricitabine/tenofovir + dolutegravir
- Abacavir/lamivudine( (Epzicom) + dolutegravir OR abacavir/lamivudine/dolutegravir (Triumeq)
- Emtricitabine/tenofovir/elvitegravir/cobicistat (Stribild)
- Emtricitabine/tenofovir + ritonavir + darunavir
- WHO first-line regimen
- Emtricitabine/tenofovir/efavirenz (Atripla)
- Tenofovir + lamivudine + efavirenz